Zevra Therapeutics, Inc. (ZVRA)

SEC filing

Zevra Therapeutics, Inc.

ZVRA · CIK 1434647

4 · Feb 10, 2026 · McFarlane Neil F. sold 14.63K shares at $8.56/share ($125.2K); exercised options for 37.50K shares

McFarlane Neil F. sold 14.63K shares at $8.56/share ($125.2K); exercised options for 37.50K shares

FORM 4

xslF345X05/wk-form4_1770760165.xmlSEC.gov

Graphics and non-inline formats (not embedded below).